Business Description
Carilex Medical Inc
ISIN : TW0007726002
Description
Carilex Medical Inc is a company engaged in the wound care industry by developing leading-edge technology in the prevention and treatment of wounds. Their expertise is in research and development, manufacturing, and quality control and assurance allow us to provide unparalleled products in wound care management in the form of comprehensive product lines proven to prevent and manage pressure sores and wounds. They offer products in the form of Support Surfaces, Chair Cushion and Negative Pressure Wound Therapy.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.8 | |||||
| Equity-to-Asset | 0.64 | |||||
| Debt-to-Equity | 0.21 | |||||
| Debt-to-EBITDA | 1.09 | |||||
| Interest Coverage | 20.12 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 4.77 | |||||
| Beneish M-Score | -1.51 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 0.6 | |||||
| 3-Year EBITDA Growth Rate | -11.1 | |||||
| 3-Year EPS without NRI Growth Rate | -15.9 | |||||
| 3-Year Book Growth Rate | 3.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.35 | |||||
| 9-Day RSI | 41.27 | |||||
| 14-Day RSI | 42.62 | |||||
| 3-1 Month Momentum % | -0.57 | |||||
| 6-1 Month Momentum % | 14.12 | |||||
| 12-1 Month Momentum % | -39.63 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.48 | |||||
| Quick Ratio | 1.41 | |||||
| Cash Ratio | 1.05 | |||||
| Days Inventory | 282.68 | |||||
| Days Sales Outstanding | 55.25 | |||||
| Days Payable | 46.49 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 4.13 | |||||
| Forward Dividend Yield % | 4.13 | |||||
| 5-Year Yield-on-Cost % | 4.13 | |||||
| 3-Year Average Share Buyback Ratio | -13.7 | |||||
| Shareholder Yield % | 5.64 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 44.69 | |||||
| Operating Margin % | 7.32 | |||||
| Net Margin % | 6.36 | |||||
| FCF Margin % | 4.2 | |||||
| ROE % | 9.1 | |||||
| ROA % | 5.66 | |||||
| ROIC % | 9.89 | |||||
| 3-Year ROIIC % | -18.25 | |||||
| ROC (Joel Greenblatt) % | 20.98 | |||||
| ROCE % | 12.47 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 29.79 | |||||
| PE Ratio without NRI | 27.55 | |||||
| PS Ratio | 1.88 | |||||
| PB Ratio | 2.67 | |||||
| Price-to-Tangible-Book | 2.83 | |||||
| Price-to-Free-Cash-Flow | 47.46 | |||||
| Price-to-Operating-Cash-Flow | 33.75 | |||||
| EV-to-EBIT | 18.37 | |||||
| EV-to-EBITDA | 11.89 | |||||
| EV-to-Revenue | 1.66 | |||||
| EV-to-FCF | 39.58 | |||||
| Price-to-Graham-Number | 1.86 | |||||
| Price-to-Net-Current-Asset-Value | 3.28 | |||||
| Price-to-Net-Cash | 186.52 | |||||
| Earnings Yield (Greenblatt) % | 5.44 | |||||
| FCF Yield % | 2.17 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Carilex Medical Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 449.189 | ||
| EPS (TTM) (NT$) | 1.44 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 42.62 | ||
| 14-Day ATR (NT$) | 0.26918 | ||
| 20-Day SMA (NT$) | 42.935 | ||
| 12-1 Month Momentum % | -39.63 | ||
| 52-Week Range (NT$) | 33 - 75.3 | ||
| Shares Outstanding (Mil) | 20.3 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Carilex Medical Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Carilex Medical Inc Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Carilex Medical Inc Frequently Asked Questions
What is Carilex Medical Inc(ROCO:7726)'s stock price today?
The current price of ROCO:7726 is NT$42.90. The 52 week high of ROCO:7726 is NT$75.30 and 52 week low is NT$33.00.
When is next earnings date of Carilex Medical Inc(ROCO:7726)?
The next earnings date of Carilex Medical Inc(ROCO:7726) is .
Does Carilex Medical Inc(ROCO:7726) pay dividends? If so, how much?
The Dividend Yield %  of Carilex Medical Inc(ROCO:7726) is 4.13% (As of Today), Highest Dividend Payout Ratio of Carilex Medical Inc(ROCO:7726) was 0. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Carilex Medical Inc(ROCO:7726) is 4.13%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers